secwatch / observer
8-K filed May 20, 2025, 7:59 PM ET ticker INTS CIK 0001567264
regulatory confidence high sentiment negative materiality 0.70

INTENSITY THERAPEUTICS, INC. (INTS): Nasdaq/NYSE listing notice — Intensity Therapeutics receives Nasdaq non-compliance notice for stockholders' equity

INTENSITY THERAPEUTICS, INC.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

INTENSITY THERAPEUTICS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
stockholders equity
Rules
5550(b)(1)
Exact text from the filing
May 19, 2025, Intensity Therapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market (the “Notice”) based on the information provided in the Company’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025. Nasdaq Listing Rule 5550(b)(1) requires that companies listed on The Nasdaq Capital Market with a market value of listed securities o
View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

INTENSITY THERAPEUTICS, INC. filing history →

Source: SEC EDGAR
accession 0001567264-25-000042
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.